Labshake search
Citations for R&D Systems :
1 - 50 of 244 citations for 9 Z 11 E 13 Z OCTADECATRIENOIC ACID since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Evolutionary Biology 2023Quote: Caspase-8 inhibitor Z-IETD-FMK and Caspase-9 inhibitor Z-LEHD-FMK were obtained from R&D Systems and were dissolved in dimethyl sulfoxide (DMSO ...
-
bioRxiv - Immunology 2022Quote: ... or caspase-9 inhibitors (50 μM Z-LEHD-FMK, R&D Systems), respectively ...
-
bioRxiv - Cell Biology 2021Quote: ... 40 μM Z-VAD-FMK (Z-VAD, R&D Systems) and 10 μM Necrostatin-7 (Nec-7 ...
-
Caspase cleavage of Influenza A virus M2 disrupts M2-LC3 interaction and regulates virion productionbioRxiv - Microbiology 2024Quote: ... Z-VEID-FMK (R&D systems; FMK006), Z-DEVD-FMK (R&D systems FMK004) ...
-
Caspase cleavage of Influenza A virus M2 disrupts M2-LC3 interaction and regulates virion productionbioRxiv - Microbiology 2024Quote: ... Z-DEVD-FMK (R&D systems FMK004), and Z-IETD (Invivogen ...
-
bioRxiv - Cell Biology 2023Quote: ... 50 μM z-VAD-fmk (zVAD) (R&D Systems) and 5 μM necrosulfonamide (NSA ...
-
bioRxiv - Immunology 2021Quote: ... ZVAD-fmk (20 μM, Z-VAD-FMK, R&D Systems), 911 (1 μM ...
-
bioRxiv - Biochemistry 2019Quote: ... Cathepsins substrate (Z-FR-AMC) was from R&D Systems and legumain substrate (Z-AAN-AMC ...
-
bioRxiv - Immunology 2022Quote: ... caspase-8 (50 μM Z-IETD-FMK, R&D Systems) or caspase-9 inhibitors (50 μM Z-LEHD-FMK ...
-
bioRxiv - Immunology 2023Quote: ... Z-VAD-FMK (ZVAD, 001) was from R&D Systems. Z-DEVD-FMK was obtained from APExBIO ...
-
bioRxiv - Molecular Biology 2023Quote: ... and Fluorogenic Peptide Substrate VII: Z-Leu-Arg-4-methyl-7-coumarylamide (Z-LR-AMC)(Catalog # ES008) were purchased from R&D Systems (Minneapolis, MN, USA). The enzyme reactions were initiated upon addition of ice-cold of hrCTSL (96pM ...
-
bioRxiv - Bioengineering 2020Quote: ... and S10-Z was incubated with recombinant KLK2 (R&D Systems). Following pre-cleavage with recombinant enzymes ...
-
bioRxiv - Bioengineering 2020Quote: ... and S18-Z were incubated with recombinant KLK14 (R&D Systems); and S10-Z was incubated with recombinant KLK2 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2022Quote: ... The caspase 4 inhibitor (Z-YVAD-FMK, FMK005, R&D systems) was used in further experiments at the dose of 50 µM ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 1μM Caspase-8 Inhibitor Z-IETD-FMK (R&D Systems #FMK007) or the corresponding controls (0.15% DMSO and PBS 0.5% BSA (Roche #10735086001)) ...
-
bioRxiv - Microbiology 2021Quote: Stocks of the cell death inhibitors Z-VAD-FMK (R&D Systems), GSK’963 (Selleck Chemicals) ...
-
bioRxiv - Bioengineering 2020Quote: ... and S20-Z AZPs were incubated with recombinant PRSS3 (R&D Systems); S5-Z ...
-
bioRxiv - Developmental Biology 2022Quote: ... injected at E16.5 with z-VAD-fmk (R&D Systems, Cat #FMK001) at 5 μg/g body weight in 10% DMSO in PBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... For experiments with Z-VAD-fmk (R&D Systems, Inc., FMK001, Wiesbaden, Germany) cells were pre-treated with 20μM Z-VAD-fmk for 16h ...
-
bioRxiv - Microbiology 2021Quote: ... the fluorogenic substrate Z-Leu-Arg-AMC (R&D Systems, Minneapolis, MN, Unites States) was added at a concentration of 25 μM in a final assay volume of 200 μL ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... incubated with the fluorogenic peptide substrate Z-FR-AMC (150 μM; R&D Systems) and measured at a fluorometer following a 0 to 30 min incubation (ƛEx = 390 nm ...
-
bioRxiv - Molecular Biology 2023Quote: MEG-01 cells were incubated with pan-Caspase inhibitor Z-VAD-FMK (R&D Systems) up to a concentration of 10 μM ...
-
bioRxiv - Cell Biology 2023Quote: ... 9-cis retinoic acid and all-trans retinoic acid (both R&D Systems) were each dissolved in 100% DMSO ...
-
bioRxiv - Cell Biology 2022Quote: ... Degradation of Lamin-A/C was inhibited by Caspase-6 Inhibitor Z-VEID-FMK (FMK006 R&D Systems). BMDMs were treated with different concentration of Caspase-6 Inhibitor Z-VEID-FMK for 2 h before activating with LPS ...
-
bioRxiv - Cancer Biology 2021Quote: ... Negative control cells were produced by treatment with 10 μM Z-DEVD-FMK caspase-3 inhibitor (R&D systems). 200μl of cell suspension from each cell line including the negative control group was transferred into a flow cytometry tube before being treated with 2.5μl of 0.2mM NucViewTM 488 caspase-3 substrate (fluorogenic DNA dye and DEVD moiety substrate for caspase-3 ...
-
bioRxiv - Developmental Biology 2021Quote: ... embryos were cultured overnight in N2B27 “poor” media (same formulation as N2B27 media but supplemented with 0.5xB27 supplement and 0.5xN2 supplement) with pan-caspase inhibitors (100 μM, Z-VAD-FMK, FMK001, R&D Systems, USA) or equal volume of vehicle (DMSO ...
-
bioRxiv - Cancer Biology 2022Quote: ... live/dead stained and incubated with recombinant human Siglec-9 Fc chimera (#1139-SL-050) or recombinant mouse Siglec-E Fc chimera (#5806-SL-050) both from R&D systems, USA for 20 min on ice ...
-
bioRxiv - Immunology 2020Quote: ... IL-13 (rIL-13; Prepotech) or IL-25 (rIL-25; R&D Systems) (concentration ...
-
bioRxiv - Cell Biology 2021Quote: ... and IL-13 (R&D Systems) was done in Lung lysate using manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2023Quote: ... Concentration of active MMP9 on 200μg of total proteins lysate was quantified by using a Human Active MMP-9 Fluorokine E assay kit (F9M00; R&D Systems, Noyal Châtillon sur Seiche, France) according to the protocol provided by the manufacturer ...
-
bioRxiv - Developmental Biology 2019Quote: ... mouse IgG1 (R&D systems, 11); mouse IgG2b (R&D systems ...
-
bioRxiv - Immunology 2023Quote: ... and of IL-13 was determined using the mouse IL-13 DuoSet ELISA kit (DY413, R&D systems).
-
bioRxiv - Cell Biology 2023Quote: ... and IL-13 (R&D Systems; ML010) cytokines in fresh complete media and incubated at 37 degree C with 5% CO2 for an additional 3-5d to allow fusion to proceed.
-
bioRxiv - Cell Biology 2023Quote: ... and IL-13 (R&D Systems; ML010) were added in 60 ng/mL each in complete media on d3 and incubated at 37 degree C with 5% CO2 for an additional 3-5d to allow fusion to proceed ...
-
bioRxiv - Microbiology 2020Quote: ... Recombinant human MMP-9 protein and Recombinant mice MMP-9 protein were purchased from R&D systems. Commercialized DENV2-NS1 protein were purchased from Native Antigen ...
-
bioRxiv - Immunology 2022Quote: ... and MΦs with IL-4 (20ng/ml) and IL-13 (20ng/ml; denoted ‘IL4/13’ for brevity; R&D Systems) in MΦ media ...
-
bioRxiv - Immunology 2021Quote: ... or rmIL-13 (2 μg, R&D systems) in calcium- and magnesium-free phosphate buffered saline (PBS) ...
-
bioRxiv - Immunology 2022Quote: ... and IL-13 (25ng/ml, R&D Systems) were provided to cells for alternatively activated macrophage differentiation ...
-
bioRxiv - Pathology 2022Quote: ... or rIL-13 (5 µg, R&D Systems) and intratracheally instilled in 50 µL of saline on days 0 and 6 ...
-
bioRxiv - Immunology 2023Quote: ... and IL-13 (R&D Systems, Minneapolis, Minn), were measured using ELISA assays according to the manufacturer’s protocol.
-
bioRxiv - Cell Biology 2019Quote: ... E-cadherin (R&D Systems) and BSA (Fisher) ...
-
bioRxiv - Immunology 2022Quote: ... The functionalized tips were then dipped in different hIL-9 or mIL-9 (both from R&D systems) concentrations ...
-
bioRxiv - Immunology 2021Quote: ... IL-11 was quantified by using a Human IL-11 Quantikine ELISA Kit according to manufacturer instructions (R&D Systems). Statistical analysis was performed on log10-transformed values with two-way ANOVA tests and Tukey correction ...
-
bioRxiv - Neuroscience 2019Quote: ... MMP-9 (R&D Systems; Minneapolis, MN), IL-6 (Invitrogen Carlsbad ...
-
bioRxiv - Biophysics 2020Quote: ... and MMP-13 (R&D Systems, Minneapolis, MN, USA) were diluted to 50 ng/ml in the tissue explant culture medium ...
-
bioRxiv - Immunology 2020Quote: ... Mouse IL-13 DuoSet ELISA kit (R&D Systems) was used for measurement of IL-13 levels ...
-
bioRxiv - Molecular Biology 2022Quote: ... and 20 ng/ml IL-13 (R&D system) for 24 hours.
-
bioRxiv - Cancer Biology 2022Quote: ... 13 and a pan-caspase inhibitor (R&D systems), was used on cells treated with combination therapy to observe rescue from cells treated without inhibitors ...
-
bioRxiv - Neuroscience 2020Quote: ... or E (R&D Systems, Inc.). Conditioned media from triplicate culture conditions was collected after 48 hours and human CXCL5 levels measured using a human CXCL5 Quantikine Elisa Kit (R&D Systems ...
-
bioRxiv - Cell Biology 2022Quote: ... Both mouse and mixed organoids were exposed to recombinant human IL-11 (rhIL-11, R&D systems, Minneapolis, MN, USA, #218-IL) during the entire organoid culture period of 14 days.